These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 23647276)

  • 1. Therapeutic potential of cell-penetrating peptides.
    Vasconcelos L; Pärn K; Langel U
    Ther Deliv; 2013 May; 4(5):573-91. PubMed ID: 23647276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic applications of cell-penetrating peptides.
    Johnson RM; Harrison SD; Maclean D
    Methods Mol Biol; 2011; 683():535-51. PubMed ID: 21053155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-penetrating peptides as a novel transdermal drug delivery system.
    Nasrollahi SA; Taghibiglou C; Azizi E; Farboud ES
    Chem Biol Drug Des; 2012 Nov; 80(5):639-46. PubMed ID: 22846609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-penetrating peptides for drug delivery across membrane barriers.
    Foged C; Nielsen HM
    Expert Opin Drug Deliv; 2008 Jan; 5(1):105-17. PubMed ID: 18095931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct cytosolic delivery of cargoes in vivo by a chimera consisting of D- and L-arginine residues.
    Ma Y; Gong C; Ma Y; Fan F; Luo M; Yang F; Zhang YH
    J Control Release; 2012 Sep; 162(2):286-94. PubMed ID: 22824782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell entry of cell penetrating peptides: tales of tails wagging dogs.
    Jones AT; Sayers EJ
    J Control Release; 2012 Jul; 161(2):582-91. PubMed ID: 22516088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constrained and UV-activatable cell-penetrating peptides for intracellular delivery of liposomes.
    Hansen MB; van Gaal E; Minten I; Storm G; van Hest JC; Löwik DW
    J Control Release; 2012 Nov; 164(1):87-94. PubMed ID: 23085152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-penetrating properties of the transactivator of transcription and polyarginine (R9) peptides, their conjugative effect on nanoparticles and the prospect of conjugation with arsenic trioxide.
    Kanwar JR; Gibbons J; Verma AK; Kanwar RK
    Anticancer Drugs; 2012 Jun; 23(5):471-82. PubMed ID: 22241171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell Penetrating Peptides as Molecular Carriers for Anti-Cancer Agents.
    Borrelli A; Tornesello AL; Tornesello ML; Buonaguro FM
    Molecules; 2018 Jan; 23(2):. PubMed ID: 29385037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo biodistribution and efficacy of peptide mediated delivery.
    Järver P; Mäger I; Langel Ü
    Trends Pharmacol Sci; 2010 Nov; 31(11):528-35. PubMed ID: 20828841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-penetrating peptides, electroporation and drug delivery.
    Cahill K
    IET Syst Biol; 2010 Nov; 4(6):367-78. PubMed ID: 21073236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. siRNA delivery: from lipids to cell-penetrating peptides and their mimics.
    Gooding M; Browne LP; Quinteiro FM; Selwood DL
    Chem Biol Drug Des; 2012 Dec; 80(6):787-809. PubMed ID: 22974319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cell penetrating peptides in cancer therapy].
    Huang S; Liu YW; Jiang Y
    Sheng Li Ke Xue Jin Zhan; 2007 Oct; 38(4):301-6. PubMed ID: 18232298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-penetrating peptides: breaking through to the other side.
    Koren E; Torchilin VP
    Trends Mol Med; 2012 Jul; 18(7):385-93. PubMed ID: 22682515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-assembled peptide (CADY-1) improved the clinical application of doxorubicin.
    Li Y; Zheng X; Cao Z; Xu W; Zhang J; Gong M
    Int J Pharm; 2012 Sep; 434(1-2):209-14. PubMed ID: 22688249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cationic cell-penetrating peptides induce ceramide formation via acid sphingomyelinase: implications for uptake.
    Verdurmen WP; Thanos M; Ruttekolk IR; Gulbins E; Brock R
    J Control Release; 2010 Oct; 147(2):171-9. PubMed ID: 20620184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acylation of octaarginine: Implication to the use of intracellular delivery vectors.
    Katayama S; Hirose H; Takayama K; Nakase I; Futaki S
    J Control Release; 2011 Jan; 149(1):29-35. PubMed ID: 20144669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-penetrating peptides can confer biological function: regulation of inflammatory cytokines in human monocytes by MK2 inhibitor peptides.
    Brugnano JL; Chan BK; Seal BL; Panitch A
    J Control Release; 2011 Oct; 155(2):128-33. PubMed ID: 21600941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-penetrating peptides, PepFects, show no evidence of toxicity and immunogenicity in vitro and in vivo.
    Suhorutsenko J; Oskolkov N; Arukuusk P; Kurrikoff K; Eriste E; Copolovici DM; Langel U
    Bioconjug Chem; 2011 Nov; 22(11):2255-62. PubMed ID: 21978260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetrating the cell membrane, thermal targeting and novel anticancer drugs: the development of thermally targeted, elastin-like polypeptide cancer therapeutics.
    Ryu JS; Kuna M; Raucher D
    Ther Deliv; 2014 Apr; 5(4):429-45. PubMed ID: 24856169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.